Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Pharmaceutical Holding Company Ltd (NY: BHVN )

71.44 USD +0.65 (+0.92%)
Official Closing Price Updated: 7:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 728,068
Open 71.92
Bid (Size) 68.00 (1)
Ask (Size) 77.77 (1)
Prev. Close 70.79
Today's Range 69.56 - 73.63
52wk Range 42.74 - 100.77
Shares Outstanding 61,915,440
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biohaven to Report First Quarter 2021 Financial Results and Recent Business Developments on May 10, 2021
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and... 
From PR Newswire
Biohaven Highlights Neuroscience Advancements with 22 Presentations at the 2021 American Academy of Neurology (AAN) Virtual Annual Meeting
- Pivotal trial of rimegepant for the preventive treatment of migraine spotlights reduction of 4.3 monthly migraine days during weeks 9-12 and rapid onset of preventive effects observed within the... 
From PR Newswire

Performance

YTD
-12.78%
-12.78%
1 Month
+0.73%
+0.73%
3 Month
-19.50%
-19.50%
6 Month
-12.03%
-12.03%
1 Year
+49.90%
+49.90%

More News

Read More
Biohaven Announces Preliminary 1Q2021 Net Product Revenue For NURTEC ODT
From PR Newswire
Rick Ware Racing, Biohaven's Nurtec ODT and Nine Line Apparel Honor Fallen Service Members
From PR Newswire
Biohaven Enrolls First Patient in Phase 2/3 Trial of Oral Zavegepant, Prompting $100 Million Milestone Funding Payment from Royalty Pharma
From PR Newswire
Noteworthy Friday Option Activity: BHVN, GEF, IIPR
Tags Stocks
From Market News Video
Biohaven Announces Pricing Of $200 Million Public Offering Of Common Shares
From PR Newswire
December 17th Options Now Available For Biohaven Pharmaceutical Holding (BHVN)
Tags Stocks
From Market News Video
Biohaven Crushes Forecasts; What's Next For Its Blockbuster Hopeful?
From Investor's Business Daily
Biohaven Secures $100M Milestone Funding After Enrolling First Patient In Migraine Study With Oral Zavegepant
Tags Biotech News Health Care
From Benzinga
Dow Moves Lower as S&P 500 Eyes New Peak
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.